Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01530984
Title Ipilimumab and GMCSF Immunotherapy for Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements No
Sponsors Lawrence Fong
Indications

prostate cancer

Therapies

Sargramostim

Ipilimumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco California 94115 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field